Summative Usability Study of Ciprofloxacin Dry Powder for Inhalation Using Placebo
The rationale of this study is to conduct a summative (i.e., validation) usability test of Ciprofloxacin Dry Powder for Inhalation (DPI) and the associated Instructions for Use.
No Inclusion Criteria Available
Inclusion Criteria - Subjects (male and female) with non-cystic fibrosis bronchiectasis (NCFB) or chronic obstructive pulmonary disease (COPD) - Subjects must be aged ≥40 - Subject must be able to independently manage and administer their NCFB/COPD medications - Subjects with recent exacerbation - Subjects with recent significant hemoptysis in the four weeks before screening (and/or during the screening period) - Subjects allergic to quinine - Known chronic bronchial asthma
Multicenter Summative Usability Study of Ciprofloxacin Dry Powder for Inhalation in Subjects with Non-Cystic Fibrosis Bronchiectasis (NCFB) or Chronic Obstructive Pulmonary Disease (COPD) Using Matching Placebo
Single Group Assignment